Micah Hartwell, Ashley Keener, Kristyn Robling, Mackenzie Enmeier, Nicholas B Sajjadi, Benjamin Greiner, Jameca Price
{"title":"Associations of intimate partner violence and maternal comorbidities: a cross-sectional analysis of the Pregnancy Risk Assessment Monitoring System.","authors":"Micah Hartwell, Ashley Keener, Kristyn Robling, Mackenzie Enmeier, Nicholas B Sajjadi, Benjamin Greiner, Jameca Price","doi":"10.1515/jom-2023-0018","DOIUrl":null,"url":null,"abstract":"<p><strong>Context: </strong>Intimate partner violence (IPV) occurs when an intimate partner inflicts physical, sexual, and/or emotional assault with coercive control and is a traumatic experience with repercussions that can be exacerbated when a woman is pregnant. While screening for IPV during pregnancy is recommended to occur regardless of risk, less than 50% of pregnant women are screened.</p><p><strong>Objectives: </strong>Identifying clinical factors commonly associated with IPV during pregnancy may improve screening rates, thus our primary objective was to examine associations between IPV and maternal comorbidities.</p><p><strong>Methods: </strong>We conducted a cross-sectional analysis of the Pregnancy Risk Assessment Monitoring System (PRAMS) Phase 8 spanning 2016 through 2019. Bivariate and multivariable logistic regression was utilized to calculate adjusted odds ratios (AORs) to determine associations between IPV and diabetes, anxiety, hypertension, depression, asthma, polycystic ovary syndrome (PCOS), and thyroid disease.</p><p><strong>Results: </strong>More than 40% of women experiencing IPV reported a history of depression or anxiety. The occurrence of IPV was higher among women with depression (AOR 3.48, CI 3.14-3.85), anxiety (AOR 2.98, CI 2.64-3.37), hypertension (AOR 1.21, CI 1.02-1.44), and asthma (AOR 1.37; CI 1.17-1.59) than women without those respective conditions, but not among diagnoses of diabetes, PCOS, or thyroid disorders.</p><p><strong>Conclusions: </strong>Our findings show that pregnant individuals reporting having experienced IPV were more likely to report having certain comorbidities compared to those who did not report experiencing IPV. Given the low rates of screening, knowing clinically relevant associations may increase screening sensitivity among clinicians and, in turn, increase the likelihood that individuals experiencing IPV receive supportive care.</p>","PeriodicalId":36050,"journal":{"name":"Journal of Osteopathic Medicine","volume":"123 8","pages":"405-410"},"PeriodicalIF":1.4000,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Osteopathic Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1515/jom-2023-0018","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Context: Intimate partner violence (IPV) occurs when an intimate partner inflicts physical, sexual, and/or emotional assault with coercive control and is a traumatic experience with repercussions that can be exacerbated when a woman is pregnant. While screening for IPV during pregnancy is recommended to occur regardless of risk, less than 50% of pregnant women are screened.
Objectives: Identifying clinical factors commonly associated with IPV during pregnancy may improve screening rates, thus our primary objective was to examine associations between IPV and maternal comorbidities.
Methods: We conducted a cross-sectional analysis of the Pregnancy Risk Assessment Monitoring System (PRAMS) Phase 8 spanning 2016 through 2019. Bivariate and multivariable logistic regression was utilized to calculate adjusted odds ratios (AORs) to determine associations between IPV and diabetes, anxiety, hypertension, depression, asthma, polycystic ovary syndrome (PCOS), and thyroid disease.
Results: More than 40% of women experiencing IPV reported a history of depression or anxiety. The occurrence of IPV was higher among women with depression (AOR 3.48, CI 3.14-3.85), anxiety (AOR 2.98, CI 2.64-3.37), hypertension (AOR 1.21, CI 1.02-1.44), and asthma (AOR 1.37; CI 1.17-1.59) than women without those respective conditions, but not among diagnoses of diabetes, PCOS, or thyroid disorders.
Conclusions: Our findings show that pregnant individuals reporting having experienced IPV were more likely to report having certain comorbidities compared to those who did not report experiencing IPV. Given the low rates of screening, knowing clinically relevant associations may increase screening sensitivity among clinicians and, in turn, increase the likelihood that individuals experiencing IPV receive supportive care.
背景:亲密伴侣暴力(IPV)是指亲密伴侣在强制控制下施加身体、性和/或情感攻击,是一种创伤性经历,其后果在妇女怀孕时可能会加剧。尽管建议无论风险如何都要在怀孕期间进行IPV筛查,但只有不到50%的孕妇接受了筛查。目的:确定妊娠期与IPV相关的临床因素可以提高筛查率,因此我们的主要目的是研究IPV与母体合并症之间的关系。方法:我们对妊娠风险评估监测系统(PRAMS)第8期(2016年至2019年)进行了横断面分析。采用双变量和多变量logistic回归计算校正优势比(AORs),以确定IPV与糖尿病、焦虑、高血压、抑郁、哮喘、多囊卵巢综合征(PCOS)和甲状腺疾病之间的关系。结果:超过40%经历IPV的女性报告有抑郁或焦虑史。抑郁(AOR 3.48, CI 3.14-3.85)、焦虑(AOR 2.98, CI 2.64-3.37)、高血压(AOR 1.21, CI 1.02-1.44)和哮喘(AOR 1.37;CI为1.17-1.59),但在诊断为糖尿病、多囊卵巢综合征或甲状腺疾病的女性中没有。结论:我们的研究结果表明,与没有经历IPV的孕妇相比,报告经历IPV的孕妇更有可能报告某些合并症。鉴于筛查率低,了解临床相关的关联可能会提高临床医生的筛查敏感性,进而增加经历IPV的个体接受支持性治疗的可能性。